Physician profile
Jonathan Rapp
NPI 1437343407
$12,725.30
in general payments reported to CMS, 2019-2025
40 companies · $3,413 in 2025
The $3,413 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,150 · 2020: $481 · 2021: $1,721 · 2022: $2,617 · 2023: $770 · 2024: $1,574 · 2025: $3,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,604 · Travel and Lodging: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,604.24 |
| Travel and Lodging | $1,151.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,850.53 | 2019-2025 | Triclip, Mitraclip, Absolute Pro |
| Edwards Lifesciences Corporation | $1,951.87 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $1,050.95 | 2019-2025 | |
| Medtronic, INC. | $729.66 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $728.37 | 2021-2024 | Impella |
| Aop Health US, LLC | $424.02 | 2025 | Rapiblyk |
| Janssen Pharmaceuticals, INC | $405.42 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $342.26 | 2019-2024 | Watchman Access System, Sentinel |
| Shockwave Medical, INC | $232.36 | 2021 | |
| Pfizer INC. | $206.97 | 2019-2025 | |
| Amgen INC. | $173.56 | 2019-2025 | Repatha, Repatha |
| Cardiovascular Systems INC. | $164.34 | 2019-2023 | Diamondback Coronary |
| Medtronic Vascular, INC. | $162.23 | 2019 | |
| Lantheus Medical Imaging, INC. | $153.17 | 2019-2020 | |
| Heartflow, INC. | $144.00 | 2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.